Published in Trends Immunol on April 07, 2009
Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature (2009) 9.71
Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol (2011) 2.93
Role of IL-33 in inflammation and disease. J Inflamm (Lond) (2011) 2.06
IL-33 promotes DC development in BM culture by triggering GM-CSF production. Eur J Immunol (2009) 1.74
Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity (2013) 1.67
Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem (2012) 1.55
IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One (2010) 1.54
IL-33 family members and asthma - bridging innate and adaptive immune responses. Curr Opin Immunol (2010) 1.41
Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice. Mol Med (2012) 1.37
Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice. Part Fibre Toxicol (2011) 1.33
The enigmatic processing and secretion of interleukin-33. Cell Mol Immunol (2010) 1.32
High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke (2010) 1.30
Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity. Cancer Res (2014) 1.23
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice. Hepatology (2012) 1.21
Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol (2010) 1.21
IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proc Natl Acad Sci U S A (2012) 1.19
The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines. Front Immunol (2013) 1.14
TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium. Int J Biochem Cell Biol (2011) 1.12
Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci (2011) 1.11
IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. J Immunol (2014) 1.09
Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci U S A (2013) 1.09
Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J Mol Cell Cardiol (2013) 1.08
The double-stranded RNA analogue polyinosinic-polycytidylic acid induces keratinocyte pyroptosis and release of IL-36γ. J Invest Dermatol (2012) 1.08
IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling. J Clin Invest (2013) 1.08
IL-33: a novel danger signal system in atopic dermatitis. J Invest Dermatol (2012) 1.05
Interleukin 33 is a guardian of barriers and a local alarmin. Nat Immunol (2016) 1.04
A carbon nanotube toxicity paradigm driven by mast cells and the IL-₃₃/ST₂ axis. Small (2012) 1.02
Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci (2011) 1.02
IL-33 induces IL-9 production in human CD4+ T cells and basophils. PLoS One (2011) 1.02
Interleukin 33: a switch-hitting cytokine. Curr Opin Immunol (2014) 1.01
Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells. J Immunol (2014) 1.00
Comparative study of the cytokine/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease. PLoS One (2013) 0.99
Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss. PLoS One (2012) 0.98
Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies. Front Immunol (2013) 0.91
Anti-viral CD8 T cells and the cytokines that they love. Virology (2013) 0.91
Epithelial, dendritic, and CD4(+) T cell regulation of and by reactive oxygen and nitrogen species in allergic sensitization. Biochim Biophys Acta (2011) 0.90
Hypoxia-inducible factor-1α and interleukin 33 form a regulatory circuit to perpetuate the inflammation in rheumatoid arthritis. PLoS One (2013) 0.89
Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction. Cardiovasc Diabetol (2011) 0.87
Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells. Neuro Oncol (2013) 0.86
Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice. Immunology (2013) 0.86
The role of interleukin-33 in rhinitis. Curr Allergy Asthma Rep (2013) 0.86
ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS One (2011) 0.85
The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice. Gastroenterol Res Pract (2010) 0.85
IL-33/ST2 pathway and classical cytokines in end-stage heart failure patients submitted to left ventricular assist device support: a paradoxic role for inflammatory mediators? Mediators Inflamm (2013) 0.85
Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases. Infect Immun (2015) 0.84
The sterile inflammation in the exacerbation of HBV-associated liver injury. Mediators Inflamm (2015) 0.83
Immunology: The expanding T(H)2 universe. Nature (2010) 0.83
Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences. J Invest Dermatol (2015) 0.83
Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients. Sci Rep (2014) 0.83
Interleukin-33 in the human placenta. J Matern Fetal Neonatal Med (2012) 0.82
The alarmin concept applied to human renal transplantation: evidence for a differential implication of HMGB1 and IL-33. PLoS One (2014) 0.82
Alarmin IL-33 elicits potent TB-specific cell-mediated responses. Hum Vaccin Immunother (2015) 0.82
IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis. Mol Carcinog (2016) 0.81
IL-1α is a DNA damage sensor linking genotoxic stress signaling to sterile inflammation and innate immunity. Sci Rep (2015) 0.81
The role of IL-33 in rheumatic diseases. Clin Dev Immunol (2013) 0.80
The physiopathological role of IL-33: new highlights in bone biology and a proposed role in periodontal disease. Mediators Inflamm (2014) 0.80
Murine mast cells secrete and respond to interleukin-33. J Interferon Cytokine Res (2013) 0.80
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases. Biomed Res Int (2014) 0.79
Inflammation in acute and chronic pancreatitis. Curr Opin Gastroenterol (2015) 0.79
Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis. Sci Rep (2016) 0.78
Genetic variant in IL-33 is associated with idiopathic recurrent miscarriage in Chinese Han population. Sci Rep (2016) 0.77
Mutated major histocompatibility complex class II transactivator up-regulates interleukin-33-dependent differentiation of Th2 subset through Nod2 binding for NLR (NOD-like receptor) signaling initiation. J Biol Chem (2012) 0.77
Role of necroptosis in the pathogenesis of solid organ injury. Cell Death Dis (2015) 0.77
Recombinant high-mobility group box 1 protein (HMGB-1) promotes myeloid differentiation primary response protein 88 (Myd88) upregulation in mouse primary cortical neurons. Neurol Sci (2012) 0.77
Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment. Nat Commun (2016) 0.76
Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells. Oncoimmunology (2015) 0.76
Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells. Br J Pharmacol (2016) 0.76
Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer. Cell Death Dis (2016) 0.76
Increased expression of upstream TH2-cytokines in a mouse model of viral-induced asthma exacerbation. J Transl Med (2016) 0.75
Potential role of the IL-33/ST2 axis in celiac disease. Cell Mol Immunol (2015) 0.75
Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33. J Transl Med (2015) 0.75
Increased levels of soluble ST2 in patients with active newly diagnosed ANCA-associated vasculitis. Mediators Inflamm (2015) 0.75
Qing Re Liang Xue Decoction Alleviates Hypercoagulability in Kawasaki Disease. Evid Based Complement Alternat Med (2015) 0.75
IL-33 Signaling in Lung Injury. Transl Perioper Pain Med (2016) 0.75
Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunity. Curr Opin Organ Transplant (2016) 0.75
Detection of soluble ST2 in human follicular fluid and luteinized granulosa cells. PLoS One (2013) 0.75
Interleukin-33 in human gliomas: Expression and prognostic significance. Oncol Lett (2016) 0.75
Regulation of IL-33 by Oncostatin M in Mouse Lung Epithelial Cells. Mediators Inflamm (2016) 0.75
Serum Interleukin-33 level in Saudi children with inflammatory bowel disease. Int J Clin Exp Pathol (2015) 0.75
TH17 cells express ST2 and are controlled by the alarmin IL-33 in the small intestine. Mucosal Immunol (2017) 0.75
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy. Immunotherapy (2017) 0.75
Cyclic stretch induced IL-33 production through HMGB1/TLR-4 signaling pathway in murine respiratory epithelial cells. PLoS One (2017) 0.75
Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol (2008) 1.76
Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab (2004) 1.51
Retinoic acid signalling in the zebrafish embryo is necessary during pre-segmentation stages to pattern the anterior-posterior axis of the CNS and to induce a pectoral fin bud. Development (2002) 1.50
Large-scale mapping of mutations affecting zebrafish development. BMC Genomics (2007) 1.21
Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol (2010) 1.21
Human placental trophoblast invasion and differentiation: a particular focus on Wnt signaling. Front Genet (2013) 1.11
Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res (2006) 1.03
Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers. Scand J Gastroenterol (2011) 1.02
The alarmin IL-33 is a notch target in quiescent endothelial cells. Am J Pathol (2012) 0.94
Chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in self-gelling alginate discs reveals novel chondrogenic signature gene clusters. Tissue Eng Part A (2011) 0.93
Macrophage-derived IL-33 is a critical factor for placental growth. J Immunol (2013) 0.93
Similar properties of chondrocytes from osteoarthritis joints and mesenchymal stem cells from healthy donors for tissue engineering of articular cartilage. PLoS One (2013) 0.92
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells. Arterioscler Thromb Vasc Biol (2012) 0.91
Transcription factor AP-2α promotes EGF-dependent invasion of human trophoblast. Endocrinology (2011) 0.89
Notch signaling plays a critical role in motility and differentiation of human first-trimester cytotrophoblasts. Endocrinology (2013) 0.89
Mice expressing L345P mutant desmin exhibit morphological and functional changes of skeletal and cardiac mitochondria. J Muscle Res Cell Motil (2008) 0.88
Molecular requirements for sorting of the chemokine interleukin-8/CXCL8 to endothelial Weibel-Palade bodies. J Biol Chem (2009) 0.86
Wnt-dependent T-cell factor-4 controls human etravillous trophoblast motility. Endocrinology (2014) 0.84
Reduced stress tolerance of glutamine-deprived human monocytic cells is associated with selective down-regulation of Hsp70 by decreased mRNA stability. J Mol Med (Berl) (2005) 0.84
Family-with-sequence-similarity-46, member A (Fam46a) gene is expressed in developing tooth buds. Arch Oral Biol (2009) 0.83
Evaluation of human first trimester decidual and telomerase-transformed endometrial stromal cells as model systems of in vitro decidualization. Reprod Biol Endocrinol (2011) 0.82
The HUVEC/Matrigel assay: an in vivo assay of human angiogenesis suitable for drug validation. Methods Mol Biol (2007) 0.82
European panel on the appropriateness of gastrointestinal endoscopy II guidelines help in selecting and prioritizing patients referred to colonoscopy--a quality control study. Scand J Gastroenterol (2014) 0.81
Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic women. J Soc Gynecol Investig (2003) 0.80
AKT isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans. Biol Reprod (2013) 0.78
Glutamine starvation of monocytes inhibits the ubiquitin-proteasome proteolytic pathway. Biochim Biophys Acta (2003) 0.77
A cost comparison of telepathology and a visiting pathologist service. J Telemed Telecare (2003) 0.75